Strategic Growth and Evolution of the Tagrisso (osimertinib) Market

добавлена новая статья Другое

2026-06-10 08:18:45 -

The Tagrisso (osimertinib) Market is fundamentally reshaping the treatment landscape for non-small cell lung cancer (NSCLC) by setting new benchmarks in clinical efficacy. The Tagrisso (osimertinib) Market was valued at USD 6.27 Billion in 2025 and is projected to grow to USD 9.20 Billion by 2033, with a compound annual growth rate (CAGR) of 4.9% from 2027 to 2033. This growth trajectory...

0 Комментарии 0 Поделились 26 Просмотры 0 предпросмотр